Portfolio company
Herlab
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
The company develops yeast-based expression systems and purification technology to manufacture low-cost antibody therapeutics for the animal health sector.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Animab
Animab develops oral monoclonal antibody products for livestock farmers to control gastrointestinal pathogens and improve animal health without using antibiotics.
PetMedix
PetMedix develops species-specific monoclonal antibody therapeutics for companion animals to treat chronic and terminal diseases in dogs and cats.
Labby
This company develops optical sensing hardware and artificial intelligence software for on-farm milk testing to help dairy farmers monitor animal health.
ArkVax
ArkVax develops low-cost recombinant glycoconjugate vaccines for the livestock industry to protect animals from bacterial diseases and combat antimicrobial resistance.
ScoutBio
The company develops monoclonal antibodies and gene therapies for pets to treat chronic diseases.
MI:RNA
This company develops microRNA and artificial intelligence based diagnostic tests to detect diseases in companion and production animals for the veterinary and agricultural sectors.
Heritable
Heritable Agriculture develops an artificial intelligence platform for plant breeding and gene editing for food and forestry companies.
ExCulture
This company develops animal-free heparin alternatives using mixed-culture fermentation for the cosmetics, medical technology and pharmaceutical industries.
